Predictors of Response to Insomnia Treatments for Gulf War Veterans
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jerome A Yesavage, MD
VA Palo Alto Health Care System, Palo Alto, CA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Va Palo Alto Health Care System, Palo Alto, Ca
Palo Alto, California, United States
- Washington Dc Va Medical Center, Washington, Dc
Washington D.C., District of Columbia, United States
- East Orange Campus of the Va New Jersey Health Care System, East Orange, Nj
East Orange, New Jersey, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Aug 2017
- Primary completion
- 21 Oct 2022
- Completion
- 21 May 2023
- Last update posted
- 26 Jan 2026
- Registered enrollment
- 50
- Registry id
- NCT03208049
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.